1.     Bursztyn M, Ben-Dov IZ. Contemporary Use of an Old Drug: Minoxidil for Resistant Hypertension. Hypertension. 2025;82(4):543-548. doi:10.1161/HYPERTENSIONAHA.124.23976
2.     Schneider R, Shril S, Buerger F, et al. Expanding the spectrum of novel candidate genes using trio exome sequencing and identification of monogenic cause in 27.5% of 320 families with steroid-resistant nephrotic syndrome. Genes Dis. 2025;12(2). doi:10.1016/j.gendis.2024.101280
3.     Ben-Dov IZ, Potruch A, Abbasi M. Prophylactic Phosphate Restriction: A Strategy to Mitigate AKI-Associated Complications. J Am Soc Nephrol. 2024;35(3):255-256. doi:10.1681/ASN.0000000000000308
4.     Khalaily N, Hassan A, Khream Y, Naveh-Many T, Ben-Dov IZ. The roles of mTORC1 in parathyroid gland function in chronic kidney disease-induced secondary hyperparathyroidism: Evidence from male genetic mouse models and clinical data. FASEB J. 2024;38(22). doi:10.1096/fj.202401547RR
5.     Hassan A, Khalaily N, Kilav-Levin R, et al. Dicer-Mediated mTORC1 Signaling and Parathyroid Gland Integrity and Function. J Am Soc Nephrol. 2024;35(9):1183-1197. doi:10.1681/ASN.0000000000000394
6.     Ben-Dov IZ. Advancing parathyroid anatomy understanding through single-cell RNA sequencing in uremic secondary hyperparathyroidism. Kidney Int. 2024;105(3):433-435. doi:10.1016/j.kint.2023.12.005
7.     Mitchell MI, Ben-Dov IZ, Liu C, et al. Non-invasive detection of orthotopic human lung tumors by microRNA expression profiling of mouse exhaled breath condensates and exhaled extracellular vesicles. Extracell Vesicles Circ Nucleic Acids. 2024;5(1):138-164. doi:10.20517/evcna.2023.77
8.     Mitchell MI, Ben-Dov IZ, Ye K, et al. Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed. J Extracell Vesicles. 2024;13(4). doi:10.1002/jev2.12440
9.     Mitchell MI, Khalil M, Ben-Dov IZ, et al. Customizing EV-CATCHER to Purify Placental Extracellular Vesicles from Maternal Plasma to Detect Placental Pathologies. Int J Mol Sci. 2024;25(10). doi:10.3390/ijms25105102
10.     Grinshpun A, Kustanovich A, Neiman D, et al. A universal cell-free DNA approach for response prediction to preoperative chemoradiation in rectal cancer. Int J Cancer. 2023;152(7):1444-1451. doi:10.1002/ijc.34392
11.     Srivastava R, Horwitz M, Hershko-Moshe A, Bronstein S, Ben-Dov IZ, Melloul D. Posttranscriptional regulation of the prostaglandin E receptor spliced-isoform EP3-γ and its implication in pancreatic β-cell failure. FASEB J. 2023;37(6). doi:10.1096/fj.202201984R
12.     Wainstein A, Hassan S, Barda S, et al. MicroRNAs expression in semen and testis of azoospermic men. Andrology. 2023;11(4):687-697. doi:10.1111/andr.13394
13.     Nechama M, Kwon J, Wei S, et al. Author Correction: The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation (Nature Communications, (2018), 9, 1, (1603), 10.1038/s41467-018-03886-6). Nat Commun. 2023;14(1). doi:10.1038/s41467-023-39297-5
14.     Amleh A, Chen HP, Watad L, et al. Arginine depletion attenuates renal cystogenesis in tuberous sclerosis complex model. Cell Reports Med. 2023;4(6). doi:10.1016/j.xcrm.2023.101073
15.     Eyal O, Ben-Dov IZ. The Role of Blood Pressure Load in Ambulatory Blood Pressure Monitoring in Adults: A Literature Review of Current Evidence. Diagnostics. 2023;13(15). doi:10.3390/diagnostics13152485
16.     Rottenberg Y, Grinshpun A, Ben-Dov IZ, Oiknine Djian E, Wolf DG, Kadouri L. Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment. JAMA Oncol. 2022;8(2):300-301. doi:10.1001/jamaoncol.2021.6764
17.     Muthukumar T, Akat KM, Yang H, et al. Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study. Transplantation. 2022;106(4):806-820. doi:10.1097/TP.0000000000003815
18.     Loudig O, Mitchell MI, Ben-Dov IZ, Liu C, Fineberg S. MiRNA expression deregulation correlates with the Oncotype DX® DCIS score. Breast Cancer Res. 2022;24(1). doi:10.1186/s13058-022-01558-4
19.     Masalha M, Meningher T, Mizrahi A, et al. MiR-199a-3p Induces Mesenchymal to Epithelial Transition of Keratinocytes by Targeting RAP2B. Int J Mol Sci. 2022;23(23). doi:10.3390/ijms232315401
20.     Ben-Dov IZ, Tzukert K, Aharon M, et al. Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients. J Nephrol. 2022;35(3):761-763. doi:10.1007/s40620-021-01235-3
21.     Ben-Dov IZ, Oster Y, Tzukert K, et al. Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months follow-up. J Nephrol. 2022;35(1):153-164. doi:10.1007/s40620-021-01210-y
22.     Hassan A, Pollak YE, Kilav-Levin R, et al. Kidney Failure Alters Parathyroid Pin1 Phosphorylation and Parathyroid Hormone mRNA-Binding Proteins Leading to Secondary Hyperparathyroidism. J Am Soc Nephrol. 2022;33(9):1677-1693. doi:10.1681/ASN.2022020197
23.     Koev I, Bloch A, Ouzan E, Zwas DR, Ben-Dov IZ, Gotsman I. Dialysis Therapy for Volume Overload: A Feasible Option to Reduce Heart Failure Hospitalizations in Advanced Heart Failure. Isr Med Assoc J. 2022;24(7):475-479. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133754464&partnerID=40&md5=159cec5eee90920b636a618e3a7e5aae
24.     Grinshpun A, Rottenberg Y, Ben-Dov IZ, Djian E, Wolf DG, Kadouri L. Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment. ESMO Open. 2021;6(6). doi:10.1016/j.esmoop.2021.100283
25.     Tzukert K, Vashdi I, Ben-Dov IZ, et al. The Effect of a 26-Hour Fast in Living Kidney Donors. Transplant Proc. 2021;53(7):2147-2152. doi:10.1016/j.transproceed.2021.07.008
26.     Max KEA, Wang VR, Chang MS, et al. Plasma microRNA Interindividual Variability in Healthy Individuals, Pregnant Women, and an Individual with a Stably Altered Neuroendocrine Phenotype. Clin Chem. 2021;67(12):1676-1688. doi:10.1093/clinchem/hvab193
27.     Mitchell MI, Ben-Dov IZ, Liu C, et al. Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV-CATCHER): A customizable purification assay designed for small-RNA biomarker identification and evaluation of circulating small-EVs. J Extracell Vesicles. 2021;10(8). doi:10.1002/jev2.12110
28.     Masalha M, Gur-Wahnon D, Meningher T, et al. IL6R is a target of miR-197 in human keratinocytes. Exp Dermatol. 2021;30(8):1177-1186. doi:10.1111/exd.14169
29.     Sever D, Hershko-Moshe A, Srivastava R, et al. NF-κB activity during pancreas development regulates adult β-cell mass by modulating neonatal β-cell proliferation and apoptosis. Cell Death Discov. 2021;7(1). doi:10.1038/s41420-020-00386-9
30.     Masalha M, Ben-Dov IZ, Ram O, et al. H3K27Ac modification and gene expression in psoriasis. J Dermatol Sci. 2021;103(2):93-100. doi:10.1016/j.jdermsci.2021.07.003
31.     Kilav-Levin R, Hassan A, Nechama M, et al. Post-transcriptional mechanisms regulating parathyroid hormone gene expression in secondary hyperparathyroidism. FEBS J. 2020;287(14):2903-2913. doi:10.1111/febs.15300
32.     Nanayakkara J, Tyryshkin K, Yang X, et al. Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining. NAR Cancer. 2020;2(3). doi:10.1093/narcan/zcaa009
33.     Azar S, Udi S, Drori A, et al. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent. Mol Metab. 2020;42. doi:10.1016/j.molmet.2020.101087
34.     Meningher T, Boleslavsky D, Barshack I, et al. Giardia lamblia mirnas as a new diagnostic tool for human giardiasis. PLoS Negl Trop Dis. 2019;13(6). doi:10.1371/journal.pntd.0007398
35.     Ben-Dov IZ, Bursztyn M. Associations of arterial stiffness indices with measures of insulin resistance and renal sodium reabsorption. Am J Hypertens. 2019;32(9):810-812. doi:10.1093/ajh/hpz082
36.     Das S, Abdel-Mageed AB, Adamidi C, et al. The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research. Cell. 2019;177(2):231-242. doi:10.1016/j.cell.2019.03.023
37.     Shuvy M, Abedat S, Eliaz R, et al. Hyperphosphatemia is required for initiation but not propagation of kidney failure-induced calcific aortic valve disease. Am J Physiol - Hear Circ Physiol. 2019;317(4):H695-H704. doi:10.1152/ajpheart.00765.2018
38.     Gluskin E, Tzukert K, Mor-Yosef Levi I, et al. Ambulatory monitoring unmasks hypertension among kidney transplant patients: Single center experience and review of the literature. BMC Nephrol. 2019;20(1). doi:10.1186/s12882-019-1442-7
39.     Max KEA, Bertram K, Akat KM, et al. Human plasma and serum extracellular small RNA reference profiles and their clinical utility. Proc Natl Acad Sci U S A. 2018;115(23):E5334-E5343. doi:10.1073/pnas.1714397115
40.     Pierdomenico SD, Pierdomenico AM, Coccina F, et al. Prognostic value of masked uncontrolled hypertension systematic review and meta-analysis. Hypertension. 2018;72(4):862-869. doi:10.1161/HYPERTENSIONAHA.118.11499
41.     Mazeh H, Deutch T, Karas A, et al. Next-generation sequencing identifies a highly accurate mirna panel that distinguishes well-differentiated thyroid cancer from benign thyroid nodules. Cancer Epidemiol Biomarkers Prev. 2018;27(8):858-863. doi:10.1158/1055-9965.EPI-18-0055
42.     Loudig O, Liu C, Rohan T, Ben-Dov IZ. Retrospective microRNA sequencing: Complementary DNA library preparation protocol using formalin-fixed paraffin-embedded RNA specimens. J Vis Exp. 2018;2018(135). doi:10.3791/57471
43.     Coenen-Stass AML, Magen I, Brooks T, et al. Evaluation of methodologies for microRNA biomarker detection by next generation sequencing. RNA Biol. 2018;15(8):1133-1145. doi:10.1080/15476286.2018.1514236
44.     Nechama M, Kwon J, Wei S, et al. The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation. Nat Commun. 2018;9(1). doi:10.1038/s41467-018-03886-6
45.     Mizrahi A, Barzilai A, Gur-Wahnon D, et al. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: The role of miR-497 in epithelial to mesenchymal transition of keratinocytes. Oncogene. 2018;37(2):218-230. doi:10.1038/onc.2017.315
46.     Gielchinsky I, Gilon M, Abu-lail R, et al. H19 non-coding RNA in urine cells detects urothelial carcinoma: a pilot study. Biomarkers. 2017;22(7):661-666. doi:10.1080/1354750X.2016.1276625
47.     Pevsner-Fischer M, Blacher E, Tatirovsky E, Ben-Dov IZ, Elinav E. The gut microbiome and hypertension. Curr Opin Nephrol Hypertens. 2017;26(1):1-8. doi:10.1097/MNH.0000000000000293
48.     Loudig O, Wang T, Ye K, et al. Evaluation and adaptation of a laboratory-based cDNA library preparation protocol for retrospective sequencing of archived microRNAs from up to 35-year-old clinical FFPE specimens. Int J Mol Sci. 2017;18(3). doi:10.3390/ijms18030627
49.     Khare D, Goldschmidt N, Bardugo A, Gur-Wahnon D, Ben-Dov IZ, Avni B. Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance. PLoS One. 2017;12(11). doi:10.1371/journal.pone.0187722
50.     Woodiwiss AJ, Norton GR, Ben-Dov IZ, Gavish B, Bursztyn M. Association of blood pressure variability ratio with glomerular filtration rate independent of blood pressure and pulse wave velocity. Am J Hypertens. 2017;30(12):1177-1188. doi:10.1093/ajh/hpx122
51.     Rotem N, Magen I, Ionescu A, et al. ALS along the Axons - Expression of coding and noncoding RNA differs in axons of ALS models. Sci Rep. 2017;7. doi:10.1038/srep44500
52.     Meningher T, Lerman G, Regev-Rudzki N, et al. Schistosomal microRNAs isolated from extracellular vesicles in sera of infected patients: a new tool for diagnosis and follow-up of human schistosomiasis. J Infect Dis. 2017;215(3):378-386. doi:10.1093/infdis/jiw539
53.     Geva GA, Gielchinsky I, Aviv N, et al. Urine cell-free microRNA as biomarkers for transitional cell carcinoma. BMC Res Notes. 2017;10(1). doi:10.1186/s13104-017-2950-9
54.     Shilo V, Levi IM-Y, Abel R, et al. Let-7 and MicroRNA-148 regulate parathyroid hormone levels in secondary hyperparathyroidism. J Am Soc Nephrol. 2017;28(8):2353-2363. doi:10.1681/ASN.2016050585
55.     Ben-Dov IZ, Whalen VM, Goilav B, Max KEA, Tuschl T. Cell and Microvesicle Urine microRNA Deep Sequencing Profiles from Healthy Individuals: Observations with Potential Impact on Biomarker Studies. PLoS One. 2016;11(1). doi:10.1371/journal.pone.0147249
56.     Vaknin-Dembinsky A, Charbit H, Brill L, et al. Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO). J Neuroinflammation. 2016;13(1). doi:10.1186/s12974-016-0648-x
57.     Bursztyn M, Norton GR, Ben-Dov IZ, et al. Aortic Pulse Pressure Amplification Imputed from Simple Clinical Measures Adds to the Ability of Brachial Pressure to Predict Survival. Am J Hypertens. 2016;29(6):754-762. doi:10.1093/ajh/hpv176
58.     Lai JY, Luo J, O’Connor C, et al. MicroRNA-21 in glomerular injury. J Am Soc Nephrol. 2015;26(4):805-816. doi:10.1681/ASN.2013121274
59.     Emde A, Eitan C, Liou L-L, et al. Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: A new mechanism for ALS. EMBO J. 2015;34(21):2633-2651. doi:10.15252/embj.201490493
60.     Shilo V, Ben-Dov IZ, Nechama M, Silver J, Naveh-Many T. Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia. FASEB J. 2015;29(9):3964-3976. doi:10.1096/fj.15-274191
61.     Houri I, Tzukert K, Levi IM-Y, et al. Implementation of guidelines for metabolic syndrome control in kidney transplant recipients: Results at a single center. Diabetol Metab Syndr. 2015;7(1). doi:10.1186/s13098-015-0083-7
62.     Li X, Ben-Dov IZ, Mauro M, Williams Z. Lowering the quantification limit of the QubitTM RNA HS Assay using RNA spike-in. BMC Mol Biol. 2015;16(1). doi:10.1186/s12867-015-0039-3
63.     Ben-Dov IZ, Tan Y-C, Morozov P, et al. Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: Description of miRNA profiles at baseline. PLoS One. 2014;9(1). doi:10.1371/journal.pone.0086856
64.     Bursztyn M, Ben-Dov IZ. Reply. J Hypertens. 2013;31(9):1910. doi:10.1097/HJH.0b013e3283635270
65.     Ben-Dov IZ, Bursztyn M. HYVET ambulatory blood pressure substudy. Hypertension. 2013;61(5):e42. doi:10.1161/HYPERTENSIONAHA.111.00884
66.     Nitzan M, Adar Y, Hoffman E, et al. Comparison of systolic blood pressure values obtained by photoplethysmography and by Korotkoff sounds. Sensors (Switzerland). 2013;13(11):14797-14812. doi:10.3390/s131114797
67.     Bursztyn M, Ben-Dov IZ. Sex differences in salt-sensitivity risk approximated from ambulatory blood pressure monitoring and mortality. J Hypertens. 2013;31(5):900-905. doi:10.1097/HJH.0b013e32835f29f4
68.     Williams Z, Ben-Dov IZ, Elias R, et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A. 2013;110(11):4255-4260. doi:10.1073/pnas.1214046110
69.     Totary-Jain H, Sanoudou D, Ben-Dov IZ, et al. Reprogramming of the MicroRNA transcriptome mediates resistance to rapamycin. J Biol Chem. 2013;288(9):6034-6044. doi:10.1074/jbc.M112.416446
70.     Farazi TA, Brown M, Morozov P, et al. Bioinformatic analysis of barcoded cDNA libraries for small RNA profiling by next-generation sequencing. Methods. 2012;58(2):171-187. doi:10.1016/j.ymeth.2012.07.020
71.     Bleumin D, Cohen MJ, Moranne O, et al. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients. J Infect. 2012;65(4):318-325. doi:10.1016/j.jinf.2012.06.005
72.     Cahan A, Ben-Dov IZ, Bursztyn M. Association of heart rate with blood pressure variability: Implications for blood pressure measurement. Am J Hypertens. 2012;25(3):313-318. doi:10.1038/ajh.2011.230
73.     Bitzer M, Ben-Dov IZ, Thum T. Microparticles and microRNAs of endothelial progenitor cells ameliorate acute kidney injury. Kidney Int. 2012;82(4):375-377. doi:10.1038/ki.2012.152
74.     Ben-Dov IZ, Muthukumar T, Morozov P, Mueller FB, Tuschl T, Suthanthiran M. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation. 2012;94(11):1086-1094. doi:10.1097/TP.0b013e3182751efd
75.     Ben-Dov IZ, Bursztyn M. Referral of women to ambulatory blood pressure monitoring. Hypertension. 2011;57(6):e26. doi:10.1161/HYPERTENSIONAHA.111.172759
76.     Ackerman Z, Pappo O, Ben-Dov IZ. The prognostic value of changes in serum ferritin levels during therapy for hepatitis C virus infection. J Med Virol. 2011;83(7):1262-1268. doi:10.1002/jmv.22093
77.     Ben-Dov IZ, Bursztyn M. Can salt sensitivity of blood pressure be assessed without changing salt diet? Hypertension. 2011;57(2):156-157. doi:10.1161/HYPERTENSIONAHA.110.163881
78.     Israel S, Israel A, Ben-Dov IZ, Bursztyn M. The morning blood pressure surge and all-cause mortality in patients referred for ambulatory blood pressure monitoring. Am J Hypertens. 2011;24(7):796-801. doi:10.1038/ajh.2011.58
79.     Cahan A, Ben-Dov IZ, Mekler J, Bursztyn M. The role of blood pressure variability in misdiagnosed clinic hypertension. Hypertens Res. 2011;34(2):187-192. doi:10.1038/hr.2010.190
80.     Ben-Dov IZ, Kark JD. Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: The Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant. 2011;26(8):2558-2566. doi:10.1093/ndt/gfq740
81.     Levi IM-Y, Ben-Dov IZ, Klimov A, Pizov G, Bloom AI. Transjugular kidney biopsy: Enabling safe tissue diagnosis in high risk patients. Isr Med Assoc J. 2011;13(7):425-427. https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960695244&partnerID=40&md5=00c4b023fa5588b76bf06f7ab6a72545
82.     Ben-Dov IZ, Cahan A, Bursztyn M. Intervisit blood pressure variability and outcome: Is heart rate a missing confounder? Hypertension. 2011;58(1):e1. doi:10.1161/HYPERTENSIONAHA.111.173641
83.     Galitzer H, Ben-Dov IZ, Silver J, Naveh-Many T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int. 2010;77(3):211-218. doi:10.1038/ki.2009.464
84.     Bursztyn M, Ben-Dov IZ. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363(26):2564-2566. doi:10.1056/NEJMc1011419
85.     Ben-Dov IZ, Bursztyn M. Increased intervisit blood pressure variability and β-blockade: Measurement imprecision related to Bradycardia? Hypertension. 2010;56(5):e48. doi:10.1161/HYPERTENSIONAHA.110.160978
86.     Ben-Dov IZ, Shuvy M. Acquired DHA nephropathy in rats. Nephrol Dial Transplant. 2010;25(10):3455-3456. doi:10.1093/ndt/gfq390
87.     Bursztyn M, Ben-Dov IZ. White-coat hypertension should not be treated in subjects with diabetes. Diabetes Care. 2009;32 Suppl 2:S310-313. doi:10.2337/dc09-s328
88.     Bursztyn M, Ben-Dov IZ. Diabetes mellitus and 24-hour ambulatory blood pressure monitoring broadening horizons of risk assessment. Hypertension. 2009;53(2):110-111. doi:10.1161/HYPERTENSIONAHA.108.119123
89.     Tolkin L, Bursztyn M, Ben-Dov IZ, Simanovsky N, Hiller N. Incidental renal artery calcifications: A study of 350 consecutive abdominal computed tomography scans. Nephrol Dial Transplant. 2009;24(7):2170-2175. doi:10.1093/ndt/gfp051
90.     Ben-Dov IZ, Pizov G, Ben-Chetrit E, Rubinger D, Or R. Fatal nephrotic syndrome complicating allogeneic stem cell transplantation: A case report. Nephrol Dial Transplant. 2009;24(9):2946-2949. doi:10.1093/ndt/gfp261
91.     Ben-Dov IZ, Bursztyn M. Ambulatory blood pressure monitoring in childhood and adult obesity. Curr Hypertens Rep. 2009;11(2):133-142. doi:10.1007/s11906-009-0024-7
92.     Ben-Dov IZ, Bursztyn M. Nondipping in patients with hypertension. Hypertension. 2009;53(5):e35. doi:10.1161/HYPERTENSIONAHA.109.131011
93.     Nechama M, Ben-Dov IZ, Silver J, Naveh-Many T. Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD. Am J Physiol - Ren Physiol. 2009;296(4):F795-F800. doi:10.1152/ajprenal.90625.2008
94.     Gavish B, Ben-Dov IZ, Kark JD, Mekler J, Bursztyn M. The association of a simple blood pressure-independent parameter derived from ambulatory blood pressure variability with short-term mortality. Hypertens Res. 2009;32(6):488-495. doi:10.1038/hr.2009.39
95.     Ben-Dov IZ. Why choose serum cystatin C levels over serum creatinine levels as a serologic marker of kidney function? Ann Intern Med. 2008;149(4):284. doi:10.7326/0003-4819-149-4-200808190-00016
96.     Galitzer H, Ben-Dov I, Lavi-Moshayoff V, Naveh-Many T, Silver J. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion. Curr Opin Nephrol Hypertens. 2008;17(4):363-367. doi:10.1097/MNH.0b013e328303e172
97.     Ben-Dov IZ, Gavish B, Kark JD, Mekler J, Bursztyn M. A modified ambulatory arterial stiffness index is independently associated with all-cause mortality. J Hum Hypertens. 2008;22(11):761-766. doi:10.1038/jhh.2008.50
98.     Nechama M, Ben-Dov IZ, Briata P, Gherzi R, Naveh-Many T. The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels. FASEB J. 2008;22(10):3458-3468. doi:10.1096/fj.08-107250
99.     Shuvy M, Abedat S, Beeri R, et al. Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats. Cardiovasc Res. 2008;79(3):492-499. doi:10.1093/cvr/cvn088
100.     Kiderman A, Ben-Dov IZ, Glikberg F, Ackerman Z. Declining frequency of liver enzyme abnormalities with statins: Experience from general practice in Jerusalem. Eur J Gastroenterol Hepatol. 2008;20(10):1002-1005. doi:10.1097/MEG.0b013e3282fdf64c
101.     Ben-Dov IZ, Mekler J, Bursztyn M. Sex Differences in Ambulatory Blood Pressure Monitoring. Am J Med. 2008;121(6):509-514. doi:10.1016/j.amjmed.2008.02.019
102.     Gavish B, Ben-Dov IZ, Bursztyn M. Linear relationship between systolic and diastolic blood pressure monitored over 24 h: Assessment and correlates. J Hypertens. 2008;26(2):199-209. doi:10.1097/HJH.0b013e3282f25b5a
103.     Gavish B, Ben-Dov IZ, Bursztyn M. Reply. J Hypertens. 2008;26(6):1268-1269. doi:10.1097/HJH.0b013e32830139e6
104.     Ben-Dov IZ, Kark JD, Mekler J, Shaked E, Bursztyn M. The white coat phenomenon is benign in referred treated patients: A 14-year ambulatory blood pressure mortality study. J Hypertens. 2008;26(4):699-705. doi:10.1097/HJH.0b013e3282f4b3bf
105.     Ben-Dov IZ, Bursztyn M. Dipping in type II diabetes: Autonomics and diuretics. J Hypertens. 2008;26(4):826. doi:10.1097/HJH.0b013e3282f55f81
106.     Ben-Dov IZ, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Increased prevalence of masked blood pressure elevations in treated diabetic subjects. Arch Intern Med. 2007;167(19):2139-2142. doi:10.1001/archinte.167.19.2139
107.     Ben-Dov IZ, Mekler J, Ben-Arie L, Bursztyn M. Lack of association between body-mass index and white-coat hypertension among referred patients. Blood Press Monit. 2007;12(2):95-99. doi:10.1097/MBP.0b013e32809efa15
108.     Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring. Int J Cardiol. 2007;117(3):355-359. doi:10.1016/j.ijcard.2006.04.088
109.     Ben-Dov IZ, Silver J. Reply [9]. Nephrol Dial Transplant. 2007;22(6):1789-1790. doi:10.1093/ndt/gfm132
110.     Ben-Dov IZ, Bursztyn M. Is siesta masking masked hypertension? Hypertension. 2007;49(4):e25. doi:10.1161/01.HYP.0000258797.25373.20
111.     Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007;117(12):4003-4008. doi:10.1172/JCI32409
112.     Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Blunted heart rate dip during sleep and all-cause mortality. Arch Intern Med. 2007;167(19):2116-2121. doi:10.1001/archinte.167.19.2116
113.     Ben-Dov IZ, Pappo O, Sklair-Levy M, et al. Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats. Nephrol Dial Transplant. 2007;22(2):362-368. doi:10.1093/ndt/gfl623
114.     Ben-Dov IZ, Bursztyn M. Editorials - Blunted sleep-related blood pressure decline in diabetic patients. Harefuah. 2007;146(1):26-27. https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847707443&partnerID=40&md5=46a75118ae2e3b9ac78560e1cd68c85c
115.     Ben-Dov IZ, Bursztyn M. Letter by Ben-Dov and Bursztyn regarding article, “role of diuretics in the prevention of heart failure: The antihypertensive and lipid-lowering treatment to prevent heart attack trial” [1]. Circulation. 2007;115(2):e18. doi:10.1161/CIRCULATIONAHA.106.639617
116.     Gavish B, Ben-Dov IZ, Bursztyn M. Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance [7]. Hypertension. 2007;50(2):e18. doi:10.1161/HYPERTENSIONAHA.107.093203
117.     Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: Unique aspects of blood pressure during sleep. Hypertension. 2007;49(6):1235-1241. doi:10.1161/HYPERTENSIONAHA.107.087262
118.     Ben-Dov IZ. Diurnal variability of hazards [1]. J Hypertens. 2007;25(2):479. doi:10.1097/HJH.0b013e3280113d5c
119.     Elinav E, Ackerman Z, Maaravi Y, Ben-Dov IZ, Ein-Mor E, Stessman J. Low alanine aminotransferase activity in older people is associated with greater long-term mortality. J Am Geriatr Soc. 2006;54(11):1719-1724. doi:10.1111/j.1532-5415.2006.00921.x
120.     Levi R, Ben-Dov IZ, Lavi-Moshayoff V, et al. Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: Correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol. 2006;17(1):107-112. doi:10.1681/ASN.2005070679
121.     Elinav E, Ben-Dov IZ, Shapira Y, et al. Acute Hepatitis A Infection in Pregnancy Is Associated With High Rates of Gestational Complications and Preterm Labor. Gastroenterology. 2006;130(4):1129-1134. doi:10.1053/j.gastro.2006.01.007
122.     Ben-Dov IZ. White-coat and masked hypertension: Selective elevation of blood pressure or an arbitrarily partitioned continuum? [1]. Hypertension. 2006;48(2):e8. doi:10.1161/01.HYP.0000228965.92166.42
123.     Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. Normal ambulatory blood pressure: A clinical-practice-based analysis of recent American Heart Association recommendations. Am J Med. 2006;119(1):69.e13-69.e18. doi:10.1016/j.amjmed.2005.08.020
124.     Ben-Dov IZ, Bursztyn M. Nondipping and impaired kidney function: Which is the cause? [3]. Arch Intern Med. 2006;166(19):2158. doi:10.1001/archinte.166.19.2158-a
125.     Ben-Dov IZ, Leibowitz D, Weiss AT. ST-segment elevation post cardioversion: A current of injury without injury [1]. Int J Cardiol. 2006;106(2):255-256. doi:10.1016/j.ijcard.2004.12.058
126.     Ben-Dov IZ. Retinal vessel narrowing: A prehypertensive or masked hypertensive state? [1]. Hypertension. 2006;47(5):e19. doi:10.1161/01.HYP.0000218339.34795.18
127.     Ben-Dov IZ, Bursztyn M. Daytime sleeping and night-time urinating obscure normal dipping. Nephrol Dial Transplant. 2006;21(1):226-227. doi:10.1093/ndt/gfi139
128.     Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. How should patients treated with α-blockers be followed? Insights from an ambulatory blood pressure monitoring database. J Hypertens. 2006;24(5):861-865. doi:10.1097/01.hjh.0000222755.69358.72
129.     Ackerman Z, Karmeli F, Pizov G, Ben-Dov I, Pappo O. Renal effects of gentamicin in chronic bile duct ligated rats. Dig Dis Sci. 2006;51(2):406-415. doi:10.1007/s10620-006-3145-8
130.     Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. Normal ambulatory blood pressure: A clinical practice-based comparison of two recently published definitions. J Hum Hypertens. 2005;19(7):565-567. doi:10.1038/sj.jhh.1001866
131.     Elinav E, Shapira Y, Ofran Y, Hassin T, Ben-Dov IZ. Near-fatal amitraz intoxication: The overlooked pesticide. Basic Clin Pharmacol Toxicol. 2005;97(3):185-187. doi:10.1111/j.1742-7843.2005.pto_97399.x
132.     Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. In clinical practice, masked hypertension is as common as isolated clinic hypertension: Predominance of younger men. Am J Hypertens. 2005;18(5):589-593. doi:10.1016/j.amjhyper.2004.11.036
133.     Ben-Dov IZ, Ben-Arieh L, Mekler J, Bursztyn M. Blood pressure dipping is reproducible in clinical practice. Blood Press Monit. 2005;10(2):79-84. doi:10.1097/00126097-200504000-00005
134.     Ben-Dov IZ. Unmasking hypertension: Are both methods equal? Am J Hypertens. 2005;18(6):779. doi:10.1016/j.amjhyper.2005.02.015
135.     Ben-Dov IZ, Bursztyn M, Jamieson MJ. Ambulatory blood pressure monitoring may be a prognostic marker in people with heart failure: Commentary 1 and 2. Evid Based Cardiovasc Med. 2005;9(3):197-201. doi:10.1016/j.ebcm.2005.06.046
136.     Elinav E, Ben-Dov I, Hai-Am E, Ackerman Z, Ofran Y. The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy. J Hepatol. 2005;42(1):82-86. doi:10.1016/j.jhep.2004.09.009
137.     Elinav E, Ben-Dov IZ, Ackerman E, et al. Correlation between serum alanine aminotransferase activity and age: An inverted U curve pattern. Am J Gastroenterol. 2005;100(10):2201-2204. doi:10.1111/j.1572-0241.2005.41822.x
138.     Ben-Dov IZ, Bursztyn M. Body mass index and ambulatory blood pressure monitoring. Hypertension. 2005;46(1):e1;authorreplye1-2. doi:10.1161/01.hyp.0000172639.98851.25
139.     Ben-Dov IZ, Perk G, Ben-Arie L, Mekler J, Bursztyn M. Pulse pressure is more susceptible to the white coat effect than is systolic blood presure: Observations from real-life ambulatory blood pressure monitoring. Am J Hypertens. 2004;17(6):535-539. doi:10.1016/j.amjhyper.2004.02.018
140.     Ben-Dov IZ, Meiner V, Eid A. Kidney transplantation unraveling Wolfram syndrome: A case report. Transplantation. 2001;72(5):958-960. doi:10.1097/00007890-200109150-00037
141.     Chemtob D, Weiler-Ravell D, Ben-Dov I. Incorrect estimation of TB drug resistance in Israel, probably due to recruitment and collection biases [2] (multiple letters). Int J Tuberc Lung Dis. 2000;4(10):990-992. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033772615&partnerID=40&md5=a5e48dd1b584c45737544d6afc759387
142.     Sosna J, Shulimzon T, Roznman J, et al. Drug-resistant pulmonary tuberculosis in Israel, a society of immigrants: 1985-1994. Int J Tuberc Lung Dis. 1999;3(8):689-694. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032768801&partnerID=40&md5=52384a80f630c5e2636e3ad265fb0aaf
143.     Bardea A, Dagan A, Ben-Dov I, Amit B, Willner I. Amplified microgravimetric quartz-crystal-microbalance analyses of oligonucleotide complexes: A route to a Tay-Sachs biosensor device. Chem Commun. 1998;(7):839-840. doi:10.1039/a800215k
144.     Blonder R, Levi S, Tao G, Ben-Dov I, Willner I. Development of amperometric and microgravimetric immunosensors and reversible immunosensors using antigen and photoisomerizable antigen monolayer electrodes. J Am Chem Soc. 1997;119(43):10467-10478. doi:10.1021/ja971980z
145.     Blonder R, Ben-Dov I, Dagan A, Willner I, Zisman E. Photochemically-activated electrodes: Application in design of reversible immunosensors and antibody patterned interfaces. Biosens Bioelectron. 1997;12(7):627-644. doi:10.1016/S0956-5663(97)00022-5
146.     Ben-Dov I, Willner I, Zisman E. Piezoelectric Immunosensors for Urine Specimens of Chlamydia trachomatis Employing Quartz Crystal Microbalance Microgravimetric Analyses. Anal Chem. 1997;69(17):3506-3512. doi:10.1021/ac970216s
147.     Lion-Dagan M, Ben-Dov I, Willner I. Microgravimetric quartz-crystal microbalance analysis of cytochrome c interactions with pyridine and pyridine-nitrospiropyran monolayer electrodes: Characterization of inter-protein complexes at the functionalized surfaces. Colloids Surfaces B Biointerfaces. 1997;8(4-5):251-260. doi:10.1016/S0927-7765(97)00008-8
148.     Ranjit KT, Marx-Tibbon S, Ben-Dov I, Willner I. Formation of Supramolecular Donor - Acceptor Complexes between Bis(pyridiniomethyl)azobenzenes and Eosin in Solutions and at Solid Interfaces: Transduction into Optical and Microgravimetric Signals. Angew Chemie (International Ed English). 1997;36(1-2):147-150. doi:10.1002/anie.199701471
149.     Narvaez A, Dominguez E, Katakis I, et al. Microperoxidase-11-mediated reduction of hemoproteins: Electrocatalyzed reduction of cytochrome c, myoglobin and hemoglobin and electrocatalytic reduction of nitrate in the presence of cytochrome-dependent nitrate reductase. J Electroanal Chem. 1997;430(1-2):227-233. doi:10.1016/S0022-0728(97)00242-8
150.     Marx-Tibbon S, Ben-Dov I, Willner I. Electrochemical and quartz-crystal-microbalance transduction of light-controlled supramolecular interactions at monolayer-functionalized electrodes. J Am Chem Soc. 1996;118(19):4717-4718. doi:10.1021/ja960172p
151.     Ranjit KT, Marx-Tibbon S, Ben-Dov I, Willner B, Willner I. Light-stimulated formation and dissociation of supramolecular donor-acceptor complexes between eosin and bipyridinium azobenzenes: Design of molecular electronic devices for the piezoelectrical transduction of recorded optical signals. Isr J Chem. 1996;36(4):407-419. doi:10.1002/ijch.199600055
152.     Springer C, Goldenberg B, Dov IB, Godfrey S. Clinical, physiologic, and psychologic comparison of treatment by cromolyn or theophylline in childhood asthma. J Allergy Clin Immunol. 1985;76(1):64-69. doi:10.1016/0091-6749(85)90806-1